Does amitriptyline help for irritable bowel syndrome pain management?: An updated systematic review and meta-analysis
Amitriptyline significantly confers short-term improvements in abdominal pain and global IBS symptoms, but the certainty of evidence is limited by generally short follow-up, variable study quality, and incomplete reporting of safety and withdrawals. Longer, well-designed trials with standardized outcomes and systematic adverse-event monitoring are needed to clarify long-term effectiveness and tolerability.
Authors
- Ghosoon Bafaraj
- Raghad Alhajaji (ORCID: https://orcid.org/0000-0002-8776-3419)
- Manal Z. Alfahmi (ORCID: https://orcid.org/0000-0001-7024-2978)
- Alaa Mohammad Kadah Salim
- Sara Bandar Badirah
- Eatedal Mohammed Alshareef
- Alshaymaa Khalid Mofareh
- Sultan AlDhabei
Institutions
- Umm al-Qura University (SA)
- King Faisal Specialist Hospital & Research Centre (SA)
- King Saud Medical City (SA)
- King Saud University (SA)
- King Abdulaziz Medical City (SA)
- Ministry of Health (SA)
- King Abdullah Medical City (SA)
- Batterjee Medical College
- Najran University (SA)
Publication Details
- Journal
- Medicine
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1097/md.0000000000046869
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00